参附汤加味治疗慢性心力衰竭临床研究
发布时间:2018-01-08 03:00
本文关键词:参附汤加味治疗慢性心力衰竭临床研究 出处:《中国现代药物应用》2017年08期 论文类型:期刊论文
【摘要】:目的研究参附汤加味治疗慢性心力衰竭临床疗效。方法 100例慢性心力衰竭患者根据治疗方法不同分为观察组与对照组,各50例。对照组患者采用西医对症治疗,观察组在对照组治疗的基础上采用中医辨证加服参附汤加味治疗,对比两组患者采用不同治疗方法后的临床疗效。结果观察组治疗总有效率为92%,明显高于对照组的76%,差异具有统计学意义(P0.05)。治疗前两组患者心力衰竭症状积分比较差异无统计学意义(P0.05)。治疗后两组患者心力衰竭症状积分均大幅度下降,且观察组患者衰竭症状积分明显低于对照比较,差异具有统计学意义(P0.05)。两组患者治疗前6 min步行试验和血清N端前体脑钠肽(NT-proBNP)水平比较差异无统计学意义(P0.05)。治疗后两组患者6 min步行试验和血清NT-proBNP水平均明显改善,且观察组优于对照组,差异具有统计学意义(P0.05)。结论慢性心力衰竭患者在常规对症治疗的基础上采用中医辨证加服参附汤加味治疗,能更好的改善心功能,值得推广应用。
[Abstract]:Objective to study the clinical effect of Shenfu decoction on chronic heart failure. Methods 100 patients with chronic heart failure were divided into observation group and control group according to different treatment methods. 50 cases each. The patients in the control group were treated with western medicine, while the observation group was treated with TCM syndrome differentiation and Shenfu decoction on the basis of the treatment of the control group. Results the total effective rate of the observation group was 92, which was significantly higher than that of the control group (76%). The difference was statistically significant (P 0.05). There was no significant difference in symptom score of heart failure between the two groups before treatment (P 0.05). After treatment, the symptom scores of heart failure in both groups were significantly decreased. The symptom score of failure in the observation group was significantly lower than that in the control group. The difference was statistically significant (P 0.05). There was no significant difference in walking test 6 min before treatment and serum NT-proBNPs (P < 0.05) between the two groups (. After treatment, both 6 min walking test and serum NT-proBNP level were significantly improved in both groups. And the observation group is better than the control group, the difference is statistically significant P0.05.Conclusion the patients with chronic heart failure are treated with TCM syndrome differentiation and Shenfu decoction on the basis of routine treatment. It can improve cardiac function better and is worth popularizing.
【作者单位】: 广东省开平市三埠卫生院;
【分类号】:R259
【正文快照】: 慢性心力衰竭临床又称为慢性充血性心力衰竭,主要原因在于心脏功能性疾病或者心脏器质性疾病导致射血能力损伤和心室充盈能力的损害所造成的心血管主要综合征,同时是现代医学的难题[1-4]。本次研究作者在西药常规治疗的基础上,运用中药汤剂参附汤加味治疗,取得一定成效,现将结
【相似文献】
相关期刊论文 前10条
1 赖忠民;周晓;游天国;王静;麦少云;;参附汤治疗病态窦房结综合征46例[J];中医杂志;2007年08期
2 罗试计;何复忠;黄茂政;;二仙参附汤治疗原发性甲状腺功能减退症[J];中国实验方剂学杂志;2012年03期
3 王明彦;;参附汤运用一得[J];吉林中医药;1980年02期
4 任立荣;;参附汤运用一得[J];辽宁中医杂志;1988年07期
5 王荣琴,王慧霞,刘占国,张建军;参附汤加味治疗急性心肌梗塞并发心源性休克[J];现代中西医结合杂志;1998年04期
6 王驰;参附汤加味治疗病态窦房结综合征39例[J];浙江中医学院学报;2005年04期
7 佘玉英;;参附汤用于救治危重患者1例[J];中国医药指南;2011年02期
8 胡道铭;;参附汤治验2例[J];成都中医学院学报;1979年03期
9 郑健民;;参附汤加味治愈植物神经功能紊乱一例[J];医学理论与实践;1988年02期
10 孙来银,刘广合;参附汤加减治愈高度房室传导阻滞案[J];黑龙江中医药;1994年02期
,本文编号:1395315
本文链接:https://www.wllwen.com/zhongyixuelunwen/1395315.html
最近更新
教材专著